MicroCap Conference, Essex House, New York City, October 5, 2017

by DrKSSMDPhD | October 5, 2017 6:00 am

This is premium content. To view this article (and to have full access to the rest of our articles), sign up. Already a member? Log in.

Source URL: https://sgumdev.stockgumshoe.com/2017/10/microcap-conference-essex-house-new-york-city-october-5-2017/


109 Comments
Inline Feedbacks
View all comments
ajgormican
ajgormican
4 years ago

#longevity

We know who da mann, but this one’s for Cleveland.

https://youtu.be/w3xcybdis1k

👍 338
pone67
pone67
4 years ago

I am wondering if anyone has insights on the decline of ARCA (ABIO) from $2.5 to $1 in the August timeframe. Was this entirely about the pending study review? I notice on the cash flow that they issued a lot of stock just prior to the decline, so I guess you could build a case for this being partly about dilution as well.

It looks like this company is only carrying about a quarter’s burn rate of cash on the balance sheet. So if they were to ever have a bad study result, the trip to bankruptcy would be quite rapid. This might also account for the extremely low valuation.

Dr KSS, how are you feeling about the science on ABIO after the study review?

Add a Topic
5971
Add a Topic
3932
👍 22
cw99
4 years ago
Reply to  pone67

$ABIO
Pone67, come over to the new thread. Tear Sheet: CohBar, Inc. As far as ABIO. I have 2 fairly big positions, one at 2.20 and one at 1.90. The August DMSC was indeed the reason for the drop. The results of that review had 3 potential outcomes.
1. Continue as planned (which is what they recommended)
2. Stop study b/c drug not working
3. Drug working so well, stop Phase 2, and use the SAME patients to start a Phase 3
Of course, the masses were hoping for outcome #3. When that didn’t happen SP dropped. It has been rebounding of late with a low of around 1.05, to somewhere around 1.60 yesterday.
We had a lot of great commentary from Dr KSS about it in August a few threads back. I suggest you search for those comments.
Basically, it still has very good odds of succeeding. If it does, SP will probably bump up big time, and they can start planning their Phase 3.
If it doesn’t meet endpoint, I’m sure company will try to spin it somehow, but I’m afraid that will doom them.

Add a Topic
3932
👍 1235
pone67
pone67
4 years ago
Reply to  cw99

cw99, what was your impression of the science based on the study review?

Do you see any catalyst for a re-rating for the next six months? They are stuck in extended phase 2 for another seven months now? At that point they have to go through the same kind of review?

I thought it was interesting that the comparison was to Toprol and not placebo. The fact that they showed some statistical significance to Toprol is good news.

👍 22
Lannas
Lannas
4 years ago
Reply to  pone67

PONE67 – $TICKER – PLEASE

👍 851
cw99
4 years ago
Reply to  pone67

ABIO
The reason to start every post (even a response or reply) with ticker is so it will be searchable later. As for ABIO, they will present top-line data 1Q2018, so sometime between Jan and March, not quite 7 months. I think the BEST trial was already done with placebo that showed bucindolol prevented recurrences of A fib in patients with the Arg389 genotype. Why not compare to Toprol? That’s what good trials do. I encourage you to search the threads. Start here:
https://www.sgumdev.stockgumshoe.com/2017/06/oncotutorial/comment-page-14/#comment-4945229

👍 1235
pone67
pone67
4 years ago
Reply to  cw99

After further review of $ABIO, I am going to pass on it. It was quickly obvious to me that they are hopelessly undercapitalized for where they are now. They are living off cash scraps thrown to them every six months, and how will they fund a phase 3 study?

To me the fact that management only owns less than 4% of the company speaks volumes to me. They want to fund continued science using “other peoples’ money” not their money.

I also got the feeling that the management team is academic rather than business-focused. That is also part of the reason the cash situation has become so precarious.

I will look at this again in six months.

👍 22
pone67
pone67
4 years ago

Dr KSS, you have been very prolific here, offering analysis for quite a few biotech stocks. Unfortunately, this site has no ticker-based discussion boards. And you quite often write an article on a specific company, only to close down the comments section. Would you have any objection to my going through your 2016-to-2017 picks and opening discussion for those on Stockopedia’s discussion boards, on a per-ticker basis? Stockopedia seems to attract the highest quality investors so discussions usually do not degrade into name calling. I could then cross post the opening discussion inline here.

Add a Topic
3932
👍 22
hedy1234
hedy1234
4 years ago
Reply to  pone67

Pone67
While your intentions may be pure, your request is just unreasonable.

Our Dr. Relentless already has a full plate, provides us with all his work at a personal cost and oh by the way has his own medical practice.

We have made it a practice on this board to guard his time. So while it is entirely up to him, we try to protect his time.

👍 1618
linling88
linling88
4 years ago
Reply to  pone67

NoTicker

Hi pone67, please beware of the fact that there are copyright considerations governing cross-postings or cross-quoting either and both ways.

👍 7490
mtpoulsen
mtpoulsen
4 years ago
Reply to  pone67

$No ticker
pone67 – What happens in this forum stays in this forum. We have had cases before where individuals cut and pasted into other forums and that was stopped. If bioinvestors want to get ahead and get access to the best new science value proposition in town they should sign up to SG. Remember Docs comments are his intellectual property. I do ticker searches all the time. It is quite easy.

👍 2183
👍 47658
petervr
petervr
4 years ago
Reply to  DrKSSMDPhD

Doc, you are truly a good friend and a master of understatement,
PetervR

👍 1539
hedy1234
hedy1234
4 years ago
Reply to  DrKSSMDPhD

$new forum

For what its worth I like having all stocks discussed in one boiling cauldron.

This lends itself to many side discussions of medical interest as well as cross comparisons of stocks and investing philosophy.

Not to mention the pain of signing up for a high number of individual threads.

Just one person’s input.

👍 1618
pone67
pone67
4 years ago
Reply to  DrKSSMDPhD

Any discussion forum where we can enter a ticker symbol on which you have commented, and can move forward the discussion in the context of that ticker, would be a solution.

I think it is very important – and very high value – that any time a person wants to catch up on the entire conversation that has centered around one ticker, that the person have someplace to go to read all of that conversation. Today, everything is scattered around different threads. There is no way to find much of it. Questions get duplicated. Important comments get lost.

What is the timeline for releasing the new system?

👍 22
OracleofJersey
OracleofJersey
4 years ago
Reply to  DrKSSMDPhD

Hey Doc. We never really got to hear much about the MIcrocap Conference after you had those technical difficulties. Anything earth shattering happen that we missed?

👍 18
pone67
pone67
4 years ago
Reply to  pone67

People commenting on this thread: you could have simply stated your objections without downvoting me. I was making a CONSTRUCTIVE comment, aimed at making the discussions here easier to follow. I accept the objections that were made, and at no point did I argue any of this.

Now you have completely trashed my user rating when all I wanted to do was make this a better place.

👍 22
ajgormican
ajgormican
4 years ago
Reply to  pone67

Probably for commenting on how to make the threads easier to follow, and in the next post discussing a stock without giving the ticker symbol. But it wasn’t me, here are two thumbs up. We’ll figure it out.

Add a Topic
5971
👍 338
pone67
pone67
4 years ago
Reply to  ajgormican

the first sentence of the post discussing a stock was “I am wondering if anyone has insights on the decline of ARCA (ABIO)”. Is your criticism that I did not express the stock symbol with a dollar sign? ($ABIO) I am happy to follow any conventions.

Add a Topic
5971
Add a Topic
5971
👍 22
Lannas
Lannas
4 years ago
Reply to  pone67

no ticker -pone67 – many follow discussion via e-mail so every post even reply’s need $ticker. thanks

👍 851
👍 47658
petervr
petervr
4 years ago
Reply to  pone67

pone67 – I wonder if you really understand what this site is all about ? However imperfect it is, it is the productive result of literally years of effort by intelligent and well-meaning contributors. I think the key word is “sensitivity” (on all sides).

👍 1539
hedy1234
hedy1234
4 years ago
Reply to  pone67

Pone-

Folks are really sensitive right now having been thru some recent forum pain.

Your suggestion was perfectly reasonable EXCEPT if it makes work for our Doc.

If he agrees AND someone like Travis can do the admin. Then it becomes possible.

👍 1618
Cleveland
4 years ago
Reply to  pone67

Pone Sorry but we have had a lot of problems the last several days with posters and everyone is on edge. I tried to give you thumbs up to put you back to zero. Perhaps others can lend a helping hand here. Doc’s response was fine.

I do not completely understand what you would like to do. If you want to take this offline so I can understand better what you are trying to accomplish and how that would benefit us ask the contact below to contact me and we can review. Understand there is a lot of things up in the air.

👍 6053
pone67
pone67
4 years ago
Reply to  Cleveland

, I sent my contact info to the payments email.

👍 22
Cleveland
4 years ago
Reply to  pone67

Thank you Gummies for Putting Pone67 whole again !!!! Awsome !!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!! He is new here…..

👍 6053
hedy1234
hedy1234
4 years ago

RIP
Y. A. Tittle, legendary QB for NY Giants and others. Age 90.

👍 1618